CompoAtlas

ESTHELIV OsteoMagnesium 4-in-1

Natural health product licensed in Canada

Licence holder
ESTHELIV COMPANY, LLC
NPN or DIN-HM
80148722
Status
Active licence
Licence date
30 April 2026
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo-

Source : Pyrroloquinoline quinone disodium salt

5 mgNot calculated
Magnésium

Source : Bisglycinate de magnésium

50 mg50,000 µg
Vitamine D

Source : Cholécalciférol

1,000 UI25 µg
Vitamine D

Source : Cholécalciférol

25 MicrogrammesNot calculated
Vitamine K2

Source : Ménaquinone 7

90 MicrogrammesNot calculated

Non-medicinal ingredients

Maltodextrine, Stéarate de magnésium, Hydroxypropyl méthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support the body's ability to metabolize nutrients. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80148722

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line